Top ▲

The IUPHAR/BPS Guide to PHARMACOLOGY complete ligand list

Click here for help
Includes therapeutic monoclonal antibodies.
Download as CSV

A   B   C   D   E   F   G   H   I   L   M   N   O   P   Q   R   S   T   U   V   X   Y   Z  

Ligand name ID Synonyms
A Back to top
abagovomab 8265 ACA125, MEN-2234
ABBV-154 12918 ADC11
ABBV-3373 Immunopharmacology Ligand 12917 ADC 122
abciximab Approved drug 6584 7E3 antibody, antiGPIIBIIIa, C7E3, ReoPro®
abelacimab 12417 MAA-868, MAA868, NVS250519
AbGn-168H Immunopharmacology Ligand 10013 AbGn-168, neihulizumab
abrezekimab Immunopharmacology Ligand 9806 CDP7766, UCB-4144, UCB4144, VR-942
abrilumab Immunopharmacology Ligand 11531 AMG 181, AMG-181, MEDI-7183, MEDI7183
adalimumab Approved drug Immunopharmacology Ligand 4860 D2E7, Humira®
aducanumab Approved drug 8325 aducanumab-avwa, Aduhelm®, BART, BIIB-037, BIIB037
AFM13 Immunopharmacology Ligand 10067 AFM 13, AFM-13
alemtuzumab Approved drug Immunopharmacology Ligand 6770 campath 1H, Campath®, campath-1H, Lemtrada®
alirocumab Approved drug 6744 Praluent®, REGN727, SAR-236553, SAR236553
ALT-803 Immunopharmacology Ligand 9615 IL-15 N72D:IL-15RαSu/Fc, IL-15SA, N-803
amatuximab 7750 MORAb-009
AMG820 Immunopharmacology Ligand 9106
amivantamab Approved drug 10505 amivantamab-vmjw, JNJ-61186372, JNJ-6372, JNJ61186372, Rybrevant®
AMY109 Immunopharmacology Ligand 12789 AMY-109, H1009/L395-F1974m
anatumomab mafenatox Immunopharmacology Ligand 9947 5T4FabV13SEAD227A, ABR 214936, ABR-214936, ABR214936, pMB125, PNU 214936, PNU-214936, PNU214936, TTS-CD2
andecaliximab Immunopharmacology Ligand 9510 GS-5745, GS5745
anifrolumab Approved drug Immunopharmacology Ligand 8258 anifrolumab-fnia, MDX-1333, MEDI-546, Saphnelo®
anti-FXII nanobody N4-38 13274
anti-ILT7 antibody 9124
anumigilimab 11761 CSL-324, CSL324
apitegromab 11180 SRK-015, SRK015
ASC06-IgG1 12564
atezolizumab Approved drug Immunopharmacology Ligand 7990 MPDL3280A, Tecentriq®
atibuclimab Immunopharmacology Ligand 11326 IC14
avdoralimab Immunopharmacology Ligand 11345 anti-hC5aR-32F3A6 GL, IPH-5401, NN-8210, NNC-0215-0384
avelumab Approved drug Immunopharmacology Ligand 8735 Bavencio®, MSB-0010718C, MSB0010718C
avizakimab 12270 BOS 161721, BOS161721
 
B Back to top
bamlanivimab 11325 LY-3819253, LY-CoV555, LY3819253
bapineuzumab 6930 3D-6, AAB-001
barzolvolimab 11607 CDX-0159
basiliximab Approved drug Immunopharmacology Ligand 6879 CHI-621, L04AC02, SDZ-CHI-621, Simulect®
bavituximab 8002 Tarvacin ch3G4
bebtelovimab 11921 LY-3853113, LY-CoV-1404, LY-CoV1404, LY3853113
begelomab Immunopharmacology Ligand 8691 Begendina&rg; (proprietary name), BT 5/9, SAND 26
belantamab mafodotin Approved drug Immunopharmacology Ligand 11117 belamaf, belantamab mafodotin-blmf, Blenrep®, GSK-2857916, GSK2857916
belimumab Approved drug Immunopharmacology Ligand 6887 Benlysta®, hBlySmAb-1.1, LimphoStat-B, lymphostat-B
bemarituzumab 11278 FPA-144, FPA144
benralizumab Approved drug Immunopharmacology Ligand 7674 BIW-8405, Fasenra®, KHK4563, MEDI-563
bermekimab 8089 MABp1, RA-18C3, Xilonix® (proposed trade name)
bevacizumab Approved drug 6771 Avastin®, rhuMAb-VEGF
bexmarilimab Immunopharmacology Ligand 12907 Clevegen, FP-1305, FP1305
bifikafusp alfa Immunopharmacology Ligand 9756 Darleukin, L19-IL2, L19IL2
bimagrumab 8086 BYM-338, BYM338
bimekizumab Approved drug Immunopharmacology Ligand 9411 bimekizumab-bkzx, Bimzelx®, CA028_0496, CDP4940, gL7gH9, UCB-4940, UCB4940, Zu-G1
bintrafusp alfa 11376 M7824, MSB0011359C
blinatumomab Approved drug Immunopharmacology Ligand 7384 Blincyto®, bscCD19xCD3, MEDI-538, MT-103, MT103
bococizumab 7730 PF-04950615, RN-316, RN316
BPS-804 9202 BPS 804, BPS804
brazikumab Immunopharmacology Ligand 9293 AMG 139, AMG-139, MEDI2070
brentuximab vedotin Approved drug Immunopharmacology Ligand 6772 Adcetris®, anti-CD30 ADC SGN-35, SGN 35
briakinumab Immunopharmacology Ligand 9213 ABT-874, J-695, J695, Ozespa
brodalumab Approved drug Immunopharmacology Ligand 7540 AMG-827, AMG827, Kyntheum®, Lumicef®, Siliq®
brolucizumab Approved drug 8713 Beovu®, brolucizumab-dbll, ESBA-1008, ESBA1008, RTH258
brontictuzumab 11361 OMP-52M51, OMP52M51
BsAb (CD89-CD20) Immunopharmacology Ligand 9833
burosumab Approved drug 9292 burosumab-twza, Crysvita®, KRN-23, KRN23, N5KG1_C10_LH, UX-023, UX023
 
C Back to top
cabiralizumab Immunopharmacology Ligand 9107 BMS-986227, FPA-008, FPA008
cadonilimab Approved drug Immunopharmacology Ligand 12966 AK-104, AK104
calpurbatug 13036 TRL1068
camoteskimab Immunopharmacology Ligand 13187 AEVI 007, AEVI-007, AVTX 007, AVTX-007, CERC 007, CERC-007, MEDI 2338
camrelizumab Approved drug Immunopharmacology Ligand 9758 INCSHR1210, SHR-1210
canakinumab Approved drug Immunopharmacology Ligand 6773 ACZ 885, ACZ885, Ilaris®
caplacizumab Approved drug 9123 ALX-0081, anti-vWF Nanobody, Cablivi®, caplacizumab-yhdp
capromab Approved drug 6878 capromab pendetide, CYT-351, CYT-356, Indium In 111 capromab, ProstaScint®
carotuximab 9098 c-SN6j, TRC-105, TRC105
casirivimab Approved drug 11327 REGN-10933, Ronapreve® (imdevimab + casirivimab)
catumaxomab Approved drug 7385 L01XC09, Removab®
cemiplimab Approved drug Immunopharmacology Ligand 10090 cemiplimab-rwlc, Libtayo®, REGN-2810, REGN2810, SAR-439684, SAR439684
certolizumab pegol Approved drug Immunopharmacology Ligand 6774 CDP870, Cimzia®, PHA 738144
cetuximab Approved drug 6882 C225, Erbitux®, IMC-225, IMC-C225
CFZ533 Immunopharmacology Ligand 9802 CFZ-533, iscalimab (proposed INN), NVP-CFZ533, OM11-62MF
cilgavimab Approved drug 11329 AZD1061, COV2-2130, Evusheld® (tixagevimab + cilgavimab)
CIS43 Antimalarial Ligand 11254
clazakizumab Immunopharmacology Ligand 9195 ALD-518, ALD518, BMS-945429
codrituzumab 8406 GC33, RG-7686, RG7686, RO-5137382, RO5137382
concizumab Approved drug 11182 Alhemo®, Anti-TFPI, mab2021, NN7415
COVA322 Immunopharmacology Ligand 10469
CR3022 11076
crenezumab 6934 MABT-5102A, Mabt5102A
crizanlizumab Approved drug 10550 Adakveo®, crizanlizumab-tmca, hSel001, SEG101
crotedumab 9614 REGN-1193, REGN1193
crovalimab Immunopharmacology Ligand 12790 RG-6107, RG6107, SKY59
cusatuzumab Immunopharmacology Ligand 9778 ARGX-110, ARGX110, clone 41D12
 
D Back to top
daclizumab Approved drug Immunopharmacology Ligand 6880 L04AC01, RO-24-7375, Ro-247375, Zenapax®
dalutrafusp alfa 11776 AGEN-1423, AGEN1423, GS-1423
dapirolizumab pegol Immunopharmacology Ligand 11123 CDP-7657, CDP7657, DZP
daratumumab Approved drug Immunopharmacology Ligand 7395 3003-005, Darzalex®, HuMax-CD38, JNJ-54767414
dectrekumab Immunopharmacology Ligand 8714 QAX-576, QAX576
demcizumab 8451 OMP-21M18, OMP21M18
denosumab Approved drug 6886 AMG-162, M05BX04, Prolia®, Xgeva®
depatuxizumab mafodotin 7970 ABT-414
dezamizumab 8255 GSK-2398852, GSK2398852
dinutuximab Approved drug 7979 APN-311, Ch14.18, MAb-14.18, Unituxin®
divozilimab Approved drug Immunopharmacology Ligand 13087 BCD 132, BCD-132, Ivlizi®
domagrozumab 9096 clone OGD1.0.0, PF-06252616, PF06252616
donanemab 8357
dostarlimab Approved drug Immunopharmacology Ligand 11518 ANB-011, dostarlimab-gxly, Jemperli®, TSR-042, WBP-285
dupilumab Approved drug Immunopharmacology Ligand 7574 Dupixent®, REGN668, SAR231893
durvalumab Approved drug Immunopharmacology Ligand 7985 anti-B7H1 monoclonal antibody, Imfinzi®, MEDI-4736, MEDI4736
dusigitumab 7749 MEDI-573
DX-2507 Immunopharmacology Ligand 9959
 
E Back to top
eblasakimab 11770 ASLAN-004, ASLAN004, CSL 334, CSL-334
eculizumab Approved drug Immunopharmacology Ligand 6884 h5G1.1, h5G1.1VHC, Soliris®
edrecolomab Approved drug 7984 17-1A, PANOREX® (proposed trade name)
efalizumab Approved drug Immunopharmacology Ligand 6593 anti alphaL integrin, antiCD11 alpha, hu1124, Raptiva®
efgartigimod alfa Approved drug Immunopharmacology Ligand 9777 ARGX-113, efgartigimod alfa-fcab, Vyvgart®
efmarodocokin alfa 12212 IL-22Fc, RG 7880, RG7880, UTTR1147A
eldelumab Immunopharmacology Ligand 9047 BMS-936557, MDX-1100
elezanumab Immunopharmacology Ligand 9290 ABT-555, AE12-1Y-QL
elgemtumab 8715 LJM716, NVS201010
elotuzumab Approved drug Immunopharmacology Ligand 8361 BMS-901608, Empliciti®, HuLuc63
elranatamab Approved drug Immunopharmacology Ligand 12889 elranatamab-bcmm, Elrexfio®, PF-06863135, PF06863135
emactuzumab Immunopharmacology Ligand 8944 RG7155, RO5509554
emapalumab Approved drug Immunopharmacology Ligand 9295 emapalumab-lzsg, Gamifant®, NI-0501, NI0501
emfizatamab 12177 GNC 038, GNC-038, GNC038
emibetuzumab 7748 LA480, LY-2875358, LY2875358
emicizumab Approved drug 9744 ACE-910, ACE910, emicizumab-kxwh, Hemlibra®, RG6013
enfortumab vedotin Approved drug 10738 ASG-22CE, enfortumab vedotin-ejfv, Padcev®
enoblituzumab Immunopharmacology Ligand 9589 MGA-271, MGA271
enokizumab Immunopharmacology Ligand 8934 7F3com-2H2, MEDI-528, MEDI528
envafolimab Approved drug Immunopharmacology Ligand 10492 Envida®, KN-035, KN035
epcoritamab Approved drug Immunopharmacology Ligand 11442 epcoritamab-bysp, Epkinly®, GEN-3013, GEN3013, Tepkinly®
epratuzumab Immunopharmacology Ligand 8088 90Y-DOTA-hLL2, 90Y-epratuzumab tetraxetan, 90Y-hLL2, AMG-412, IMMU-hLL2, LymphoCide® (proposed proprietary name)
eptinezumab Approved drug 10694 ALD-403, ALD403, eptinezumab-jjmr, Vyepti®
erenumab Approved drug 9250 Aimovig®, AMG 334, AMG-334, erenumab-aooe
etaracizumab 6596 etaratuzumab, hLM60, MEDI-522
etesevimab 11331 CB-6, JS-016, LY-CoV016, LY3832479
etrolizumab Immunopharmacology Ligand 8407 PRO145223, RG-7413, RG7413, rhuMAb Beta7
evinacumab Approved drug 8717 evinacumab-dgnb, Evkeeza®, REGN1500
evolocumab Approved drug 7343 AMG-145, AMG145, Repatha®
 
F Back to top
factor XIIa blocking antibody 3F7 12771
faricimab Approved drug 11420 faricimab-svoa, RG-7716, RG7716, RO-6867461, RO6867461, Vabysmo®
fasinumab 8965 REGN475, SAR164877
feladilimab 11649 GSK-3359609
fezakinumab Immunopharmacology Ligand 9281 ILV-094
fibatuzumab 8925 KB-004, KB004
fontolizumab Immunopharmacology Ligand 9847 HuZAF
fremanezumab Approved drug 9208 Ajovy®, fremanezumab-vfrm, LBR-101, PF-04427429, PF-4427429, RI-307, RN-307, RN307, TEV-48125
fresolimumab 8264 GC1008, PET1073G12
fulranumab 8964 AMG-403, JNJ-42160443
 
G Back to top
galcanezumab Approved drug Immunopharmacology Ligand 8967 clone III, Emgality®, galcanezumab-gnlm, LY-2951742, LY2951742
galegenimab 11759 15H6v4.D221, FHTR2163, RG-6147, RG6147, RO-7171009, RO7171009
gantenerumab 6933 R-1450, RG-1450, Ro-4909832
gemtuzumab ozogamicin Approved drug Immunopharmacology Ligand 6775 CDP 771, CMA 676, hP67.6-calicheamicin, Mylotarg®, WAY-CMA 676
gevokizumab Immunopharmacology Ligand 7394 XOMA 052, XOMA-052
gimsilumab Immunopharmacology Ligand 9624 MORAb-022
ginisortamab 11769 MP5D2_CL22A3, UCB-6114
girentuximab 7987 cG250, G250, Rencarex® (proposed proprietary name), WX-G250
glembatumumab vedotin 8926 CDX-011, CR011-vcMMAE
glofitamab Approved drug 12758 CD20-TCB (2:1), Columvi®, glofitamab-gxbm, RG-6026, RG6026
glunomab 13183 glunozumab
golimumab Approved drug Immunopharmacology Ligand 6776 CNTO-148, CNTO148, Simponi®
GSK3050002 Immunopharmacology Ligand 9623 E6071, KANAb071
guselkumab Approved drug Immunopharmacology Ligand 7998 CNTO-1959, Tremfya®
 
H Back to top
hIMB1636-MMAE 12978
 
I Back to top
ianalumab Immunopharmacology Ligand 10656 VAY-736, VAY736
ibalizumab Approved drug Immunopharmacology Ligand 10208 Hu5A8, ibalizumab-uiyk, TMB-355, TMB355, TNX-355, Trogarzo®
ibritumomab tiuxetan Approved drug Immunopharmacology Ligand 6777 IDEC-2B8, IDEC-Y2B8-yttrium ibritumomab tiuxetan, NSC-715848, Zevalin®
idarucizumab Approved drug 8298 aDabi-Fab, BI 655075, Praxbind®
IGN523 8737
imaprelimab Immunopharmacology Ligand 9805 PRX-003, PRX003
imdevimab Approved drug 11328 REGN-10987, REGN10987, Ronapreve® (imdevimab + casirivimab)
inclacumab Immunopharmacology Ligand 12312 HuMab 002, LC1004-002, RO-4905417, RO4905417
indusatumab vedotin 8718 5F9vcMMAE, MLN-0264, MLN0264, TAK-264, TAK264
inebilizumab Approved drug 7992 HB12, inebilizumab-cdon, MEDI 551, MEDI-551, MEDI551, Uplizna®
infliximab Approved drug Immunopharmacology Ligand 5004 cA2, Inflectra®, Remicade®, Remsima®, SB2, TA-650, Zymfentra® (subcutaneous formulation)
inotuzumab ozogamicin Approved drug Immunopharmacology Ligand 8266 Besponsa®, CMC-544
ipilimumab Approved drug Immunopharmacology Ligand 6888 MDX-010, MDX-101, MDX-CTLA-4, Yervoy®
isatuximab Approved drug 8719 ch38SB19, hu38SB19, isatuximab-irfc, SAR-650984, SAR650984, Sarclisa®
istiratumab 8930 MM-141, MM141
itolizumab Approved drug Immunopharmacology Ligand 9421 Alzumab®, T1h
ixekizumab Approved drug Immunopharmacology Ligand 7541 LY-2439821, LY2439821, Taltz®
 
L Back to top
labetuzumab 8251 CEACIDE®, hMN14
labetuzumab govitecan 8252 hMN-14-SN-38, hMN-14-SN-38 ADC, IMMU 130, IMMU-130
lampalizumab 8294 anti-factor D, FCFD4514S, RG7417
lanadelumab Approved drug 9094 DX-2930, lanadelumab-flyo, Takhzyro®, X124-G01
landogrozumab 8730 LY-2495655, LY2495655
lebrikizumab Approved drug Immunopharmacology Ligand 7684 Ebglyss®, MILR1444A, RG3637, TNX-650
lecanemab Approved drug 12202 BAN-2401, BAN2401, lecanemab-irmb, Leqembi®
lenzilumab Immunopharmacology Ligand 8935 KB-003, KB003
lepunafusp alfa 11773 JR-171, JR171
leronlimab Immunopharmacology Ligand 10752 PRO 140, PRO-140, PRO140, Vyrologix®
lifastuzumab vedotin 8405 DNIB0600A, RG-7599, RG7599
ligelizumab Immunopharmacology Ligand 8997 CL-2C, NVP-QGE031, QGE031
lilotomab Immunopharmacology Ligand 9950 Betalutin®, HH1, tetulomab
lintuzumab Immunopharmacology Ligand 7983 ACTIMAB®, HuM195, SGN-33, SMART M195
lirilumab Immunopharmacology Ligand 9310 1-7F9, BMS-986015, IPH2102
litifilimab Immunopharmacology Ligand 11122 BIIB-059, BIIB059
livmoniplimab 11762 39B6-AYE, ABBV-151, ARGX-115, ARGX115, MHG-8, MHGARP-8, PR-1762844
loncastuximab tesirine Approved drug 11521 ADCT-402, ADCT402, loncastuximab tesirine-lpyl, RB4v1.2-SG-3249, Zynlonta®
lorvotuzumab mertansine 7431 BB-10901, IMGN901
lulizumab pegol Immunopharmacology Ligand 8460 BMS-931699, BMS931699
lutikizumab Immunopharmacology Ligand 9297 ABT-981, E26.13-SS-X3
LY2928057 8416
LY3022855 Immunopharmacology Ligand 9109 IMC-CS4
 
M Back to top
MAB92 Immunopharmacology Ligand 9665
mAb 4A8 11079
magrolimab Immunopharmacology Ligand 12652 Hu5F9-G4
margetuximab Approved drug 8686 Margenza®, margetuximab-cmkb, MGAH-22
masavibart 12322 ZRC3308-A7
mavrilimumab Immunopharmacology Ligand 7785 CAM-3001, KPL-301
MCS110 Immunopharmacology Ligand 9110
meplazumab Antimalarial Ligand 11026 HP6H8, Ketantin®
mepolizumab Approved drug Immunopharmacology Ligand 7685 Nucala®, SB-240563
mezagitamab Immunopharmacology Ligand 10609 TAK-079, TAK079
milatuzumab Immunopharmacology Ligand 8267 hLL1, IMMU-115
mirikizumab Approved drug Immunopharmacology Ligand 9846 Antibody I [US9023358], LY-3074828, LY3074828, mirikizumab-mrkz, Omvoh®
mirvetuximab soravtansine Approved drug 12250 Elahere®, IMGN-853, IMGN853, M9346A-sulfo-SPDB-DM4, mirvetuximab soravtansine-gynx
mitumomab 7981 monoclonal antibody BEC2
MM-111 8931
MM-151 9125
mogamulizumab Approved drug Immunopharmacology Ligand 6477 KW-0761, mogamulizumab-kpkc, Poteligeo®
monalizumab Immunopharmacology Ligand 8323 humZ270, IPH-2201, NN8765-3658
mosunetuzumab Approved drug 12298 BTCT4465A, CD20-TDB, Lunsumio®, mosunetuzumab-axgb, RG-7828, RO7030816
moxetumomab pasudotox Approved drug Immunopharmacology Ligand 7675 CAT-8015, GCR-8015, HA22, Lumoxiti®, moxetumomab pasudotox-tdfk
mupadolimab 11758 CPI-006, CPI006, CPX-006, CPX006
muromonab-CD3 Approved drug Immunopharmacology Ligand 6889 L04AA02, OKT-3, Orthoclone Okt3®
 
N Back to top
namilumab Immunopharmacology Ligand 10370 AMG203, MT203
naptumomab estafenatox Immunopharmacology Ligand 9948 ABR-217620, ABR217620, Anyara (proposed trade name), TTS CD3, TTS-CD3
naratuximab emtansine Immunopharmacology Ligand 9949 IMGN-529, IMGN529, K7153A-SMCC-DM1
narlumosbart Approved drug 13084 Jinlitai®, JMT-103, JMT103
natalizumab Approved drug Immunopharmacology Ligand 6591 AN100226, anti-alpha4 integrin, anti-VLA4, Tysabri®
naxitamab Approved drug 11341 DANYELZA®, hu3F8, naxitamab-gqgk
necitumumab Approved drug 8090 11F8, IMC-11F8, LY3012211, Portrazza®
nemolizumab Approved drug Immunopharmacology Ligand 8720 CD14152, CIM 331, CIM331, Mitchga®
nesvacumab 8457 REGN-910, REGN910, SAR307746
nimotuzumab Approved drug 7988 h-R3, THERACIM®, Theraloc®
nivolumab Approved drug Immunopharmacology Ligand 7335 BMS-936558, MDX-1106, ONO-4538, Opdivo®
NP137 12848
nurulimab Immunopharmacology Ligand 12992 BCD-145, BCD145
 
O Back to top
obinutuzumab Approved drug Immunopharmacology Ligand 6941 GA-101, GA101, Gazyva®
obrindatamab 12586 (formerly orlotamab), MGD-009, MGD009
ocrelizumab Approved drug Immunopharmacology Ligand 7580 2H7, Ocrevus®, PRO70769, RG1594
odronextamab 12690 REGN-1979, REGN1979
ofatumumab Approved drug Immunopharmacology Ligand 6778 Arzerra®, GSK 1841157, GSK1841157, humax-CD20, Kesimpta® (subcutaneous), OMB-157, OMB157
olaratumab Approved drug 9172 IMC-3G3, Lartruvo®, LY3012207
oleclumab Immunopharmacology Ligand 9596 MEDI 9447, MEDI-9447
olokizumab 11601 CDP 6038, CDP-6038, CDP6038
omalizumab Approved drug Immunopharmacology Ligand 6890 IGE25, olizumab, R03DX05, RG-3648, rhumab-E25, Xolair®
onartuzumab 8966 MetMAb, OA-5D5, OA5D5, PRO 143966
onfekafusp alfa Immunopharmacology Ligand 9757 Fibronum, L19TNF-alpha
ontamalimab Immunopharmacology Ligand 9340 PF-00547659, PF-547659, SHP647
opicinumab 8923 BIIB-033, BIIB033
ordesekimab Immunopharmacology Ligand 13046 AMG-714, AMG714, MAb146B7, PRV-015
OSE-127 Immunopharmacology Ligand 9604 Effi-7
osocimab 11366 BAY 1213790, BAY-1213790, BAY1213790
otelixizumab 8458 ChAglyCD3, TRX4
otilimab Immunopharmacology Ligand 11132 GSK-3196165, GSK3196165, MOR-103, MOR103
otlertuzumab Immunopharmacology Ligand 9951 CD37-SMIP, TRU-016, TRU016
ozanezumab 8254 GSK-1223249, GSK1223249
ozoralizumab Immunopharmacology Ligand 9638 ATN-103, PF-5230896
 
P Back to top
pabinafusp alfa Approved drug 11772 IZCARGO®, JR-141, JR141
pamrevlumab 8928 FG-3019
panitumumab Approved drug 6883 ABX-EGF, ABX-EGF Mab, Vectibix®
pascolizumab Immunopharmacology Ligand 7786 SB-240683
pateclizumab Immunopharmacology Ligand 9854 MLTA3698A, PRO283698, RG7416
pembrolizumab Approved drug Immunopharmacology Ligand 7499 Keytruda®, lambrolizumab, MK-3475
pemtumomab 8031 HMFG1, HuHMFG-1
penpulimab Approved drug Immunopharmacology Ligand 12347 AK-105, AK105
pepinemab 8932 mAb 62-7, VX15/2503
perenostobart Immunopharmacology Ligand 12103 SRF-617, SRF617
pertuzumab Approved drug 5046 2C4, Omnitarg® (obsolete trade name), Perjeta®
PF-07062119 11125
pidilizumab 7692 BAT mAb, CT-011, MDV9300
PiN-21 11551 Pittsburgh inhalable Nanobody 21
plonmarlimab Immunopharmacology Ligand 11644 TJ 003234, TJ003234, TJM2
plozalizumab Immunopharmacology Ligand 8921 hu1D9, MLN-1202, MLN1202
polatuzumab vedotin Approved drug Immunopharmacology Ligand 8404 ACD79B-VCMMAE, polatuzumab vedotin-piiq, Polivy®, RG-7596, RG7596, RO5541077-000
pozelimab Approved drug Immunopharmacology Ligand 12900 pozelimab-bbfg, REGN-3918, REGN3918, Veopoz®
prolgolimab Immunopharmacology Ligand 12991 BCD-100, BCD100
 
Q Back to top
quilizumab Immunopharmacology Ligand 8998 47H4 v5 hulgG1, MEMP1972A, RG-7449
quisovalimab 11774 AEVI-002, AVTX-002, CERC-002, MDGN-002, SAR-252067, SAR252067
 
R Back to top
racotumomab Approved drug 7995 1E10, Vaxira®
ramucirumab Approved drug 7390 Cyramza®, IMC-1121B
ranibizumab Approved drug 6779 Fab-12 variant Y0317, Lucentis®, muMAb VEGF A.4.6.1, rhuFab V2
ravulizumab Approved drug Immunopharmacology Ligand 10168 ALXN-1210, ALXN1210, ravulizumab-cwvz, Ultomiris®
regdanvimab Approved drug 11332 CT-P-59, CT-P59, Regkirona®
relatlimab Approved drug Immunopharmacology Ligand 9536 BMS-986016, BMS986016, ONO-4482, Opdualag® (nivolumab + relatlimab-rmbw), relatlimab-rmbw
remtolumab Immunopharmacology Ligand 9597 A-1230717, ABT-122
reslizumab Approved drug Immunopharmacology Ligand 8091 CDP-835, CDP835, Cinqaero®, Cinqair®, JES1-39D10, SCH55700
retifanlimab Approved drug Immunopharmacology Ligand 11583 hPD-1 mAb 7(1.2), INCMGA0012, MGA012, retifanlimab-dlwr, Zynyz®
rilotumumab 7986 AMG 102, AMG102
risankizumab Approved drug Immunopharmacology Ligand 8922 ABBV-066, BI 655066, BI-655066, risankizumab-rzaa, Skyrizi®
rituximab Approved drug Immunopharmacology Ligand 6780 HSDB 7455, IDEC-C2B8, MabThera®, Rituxan®
rocatinlimab Immunopharmacology Ligand 13045 AMG-451, AMG451, KHK-4083, KHK4083
romosozumab Approved drug 8092 AMG-785, CDP-7851, Evenity®, romosozumab-aqqg
rontalizumab Immunopharmacology Ligand 9640 9F3v13, RhuMAB IFNalpha, rhuMAb interferon-α
rovalpituzumab tesirine 10561 Rova-T, SC0001-SCX
rovelizumab Immunopharmacology Ligand 9598 Hu23F2G, LeukArrest
rozanolixizumab Approved drug Immunopharmacology Ligand 9801 CA170_01519.g57 IgG4P, rozanolixizumab-noli, Rystiggo®, UCB-7665, UCB7665
 
S Back to top
sabatolimab 12361 MBG-453, MBG453
sacituzumab govitecan Approved drug 8253 hRS7-SN-38-ADC, IMMU-132, sacituzumab govitecan-hziy, Trodelvy®
sarilumab Approved drug Immunopharmacology Ligand 7999 Kevzara®, REGN88, SAR153191
satralizumab Approved drug Immunopharmacology Ligand 9093 Enspryng®, RG-6168, RG6168, SA-237, SA237, sapelizumab (deprecated INN), satralizumab-mwge
secukinumab Approved drug Immunopharmacology Ligand 8078 AIN 457, AIN457, Cosentyx®, NVP-AIN457
seribantumab 8297 MM-121, SAR256212
sibeprenlimab Immunopharmacology Ligand 12102 VIS-649, VIS649
sifalimumab Immunopharmacology Ligand 8257 MDX-1103, MEDI-545, MEDI545
siltuximab Approved drug Immunopharmacology Ligand 7396 cLLB8, CNTO 328, Sylvant®
simtuzumab 8412 AB0024, GS 6624, GS-6624
sintilimab Approved drug Immunopharmacology Ligand 12990 IBI 308, IBI-308, IBI308, Tyvyt®
sirexatamab 11760 DKN-01, LY-2812176, LY2812176
sirukumab Immunopharmacology Ligand 7989 CNTO 136, CNTO-136, Plivensia (proposed trade name)
solanezumab 6932 LY-2062430
sonelokimab Immunopharmacology Ligand 10491 IL17-MS3086, IL17MS3086, SEQ ID 836 [WO2012156219A1]
sotatercept 12962 ACE-011, ACE011, ActRIIA-IgG1, MK-7962, MK7962
sotevtamab 11763 16B5, AB-16B5, AB-sCLU mAb, AB16B5
sotrovimab Approved drug 11333 GSK-4182136, GSK4182136, VIR-7831, VIR7831, Xevudy®
spartalizumab Immunopharmacology Ligand 10140 NPV-PDR001, NPVPDR001, PDR-001, PDR001
spesolimab Approved drug Immunopharmacology Ligand 12169 BI-655130, BI655130, spesolimab-sbzo, Spevigo®
sugemalimab Approved drug 12342 Cejemly® (China), CS-1001, CS1001, WBP-3155, WBP3155
sutimlimab Approved drug Immunopharmacology Ligand 9807 BIVV009, Enjaymo®, IPN-009, IPN009, sutimlimab-jome, TNT009
 
T Back to top
tabalumab Immunopharmacology Ligand 8000 LY 2127399, LY2127399
tafasitamab Approved drug Immunopharmacology Ligand 11131 Minjuvi®, Monjuvi®, MOR-208, MOR00208, MOR208, tafasitamab-cxix, Xmab5574
tafolecimab Approved drug 12517 IBI-306, IBI306, Sintbilo®
talquetamab Approved drug 12240 JNJ-64407564, JNJ64407564, talquetamab-tgvs, Talvey®
tanezumab 8415 PF-04383119, PF04383119, RN624
tarextumab 8453 OMP-59R5
tarlatamab 12969 AMG 757, AMG-757, AMG757
tebentafusp Approved drug Immunopharmacology Ligand 7378 IMCgp100, Kimmtrak®, tebentafusp-tebn
teclistamab Approved drug 12233 JNJ-64007957, teclistamab-cqyv, Tecvayli®
temelimab Immunopharmacology Ligand 11530 GNbAC1
teplizumab Approved drug Immunopharmacology Ligand 12252 humanized OKT3, MGA031, PRV-031, teplizumab-mzwv, Tzield®
tepoditamab Immunopharmacology Ligand 10353 MCLA-117, MCLA117, PB9122
teprotumumab Approved drug Immunopharmacology Ligand 10612 R1507, RG-1507, RG1507, RV 001, RV-001, Tepezza®, teprotumumab-trbw
tesidolumab 8711 LFG-316, LFG316
tezepelumab Approved drug Immunopharmacology Ligand 8933 AMG 157, AMG-157, MEDI-9929, MEDI9929, tezepelumab-ekko, Tezspire®
tibulizumab Immunopharmacology Ligand 10350 LY-3090106, LY3090106
tigatuzumab 9334 CS-1008, humanized LM1 TRA-8
tildrakizumab Approved drug Immunopharmacology Ligand 8093 Ilumetri®, Ilumya®, MK-3222, MK3222, SCH-900222, SCH900222, SUNPG1623, tildrakizumab-asmn
timolumab Immunopharmacology Ligand 9097 8c10, BTT-1023, BTT1023, r8c10, SI-3106, SI-636
tislelizumab Approved drug Immunopharmacology Ligand 9592 Bai Zean®, BGB-A317, BGBA317, hu317-1/IgG4mt2, Tevimbra®, tislelizumab-jsgr
tisotumab vedotin Approved drug 11719 HuMax-TF-ADC, TF-011-MMAE, tisotumab vedotin-tftv, Tivdak®
tixagevimab Approved drug 11330 AZD8895, COV2-2196, Evusheld® (tixagevimab + cilgavimab)
tocilizumab Approved drug Immunopharmacology Ligand 6881 Actemra®, R-1569, RG-1569, RHPM-1, RoActemra®
tomaralimab Immunopharmacology Ligand 9408 OPN-305, OPN305, VK5A/H4
toripalimab Approved drug Immunopharmacology Ligand 12989 JS-001, JS001, Loqtorzi®, toripalimab-tpzi
tositumomab Approved drug Immunopharmacology Ligand 6781 Bexxar®, V10XA53
tozorakimab Immunopharmacology Ligand 12964 MEDI-3506, MEDI3506
tralokinumab Approved drug Immunopharmacology Ligand 8001 Adbry®, Adtralza®, BAK1.1, CAT-354, tralokinumab-ldrm
trastuzumab Approved drug 5082 D5v8, Herceptin®, R-597
trastuzumab emtansine Approved drug 6928 ado-trastuzumab emtansine, Kadcyla®, PRO-132365, RG-3502
tregalizumab Immunopharmacology Ligand 9864 BT-061, hB-F5
tremelimumab Approved drug Immunopharmacology Ligand 8462 CP-675, CP-675,206, CP-675206, Imjudo®, ticilimumab, tremelimumab-actl
trevogrumab 8929 REGN-1033, REGN1033, SAR-391786, SAR391786
 
U Back to top
ublituximab Approved drug Immunopharmacology Ligand 8920 Briumvi®, LFB-R603, TG-1101, TGTX-1101, ublituximab-xiiy
ulenistamab 11771 hPMAb22, PBP-1510, PBP1510
ulocuplumab Immunopharmacology Ligand 9161 BMS-936564, MDX-1338
umizortamig 12178 GNC-039, GNC039
urelumab Immunopharmacology Ligand 9311 BMS 663513, BMS-663513
ustekinumab Approved drug Immunopharmacology Ligand 6885 CNTO-1275, L04AC05, Stelara®, TT-20
utomilumab Immunopharmacology Ligand 9244 PF-05082566
 
V Back to top
vadastuximab talirine Immunopharmacology Ligand 9434 SGN-CD33A
vantictumab 10197
vanucizumab 9132 RG-7221, RG7221, RO5520985
varokibart Immunopharmacology Ligand 12187
vedolizumab Approved drug Immunopharmacology Ligand 7437 Entyvio®, LDP-02, LDP02, MLN-0002, MLN-002, MLN002
veltuzumab Immunopharmacology Ligand 8268 hA20, IMMU-106
vilobelimab 11346 CaCP-29, IFX-1
vobarilizumab Immunopharmacology Ligand 8363 ALX-0061
volociximab 10236 M200
vonlerolizumab 9245 MOXR 0916, MOXR0916, pogalizumab (deleted INN), RG7888, RO7021608
vunakizumab Immunopharmacology Ligand 9296 SHR-1314
 
X Back to top
Xilonix TN Immunopharmacology Ligand 8528
 
Y Back to top
yttrium (90Y) clivatuzumab tetraxetan Ligand is labelled Ligand is radioactive 8087 90Y-hPAM4, hPAM4, hPAM4-Cide, IMMU-107
 
Z Back to top
zagotenemab 10471 LY-3303560, LY3303560
zansecimab 11334 LY-3127804, LY3127804
zigakibart Immunopharmacology Ligand 12101 BION-1301, BION1301, clone 14_1G.15
ziltivekimab 11552 COR-001, COR001, MEDI-5117, MEDI5117, ZILTI
zimberelimab Approved drug Immunopharmacology Ligand 12349 AB-122, AB122, GLS-010
zolbetuximab 9209 claudiximab, GC-182, IMAB-362, IMAB362
ZWB67 12229 KVD900